Skip to Content

Hepacare

Active Substance: hepatitis B, recombinant surface antigen
Common Name: triple antigen hepatitis B vaccine (recombinant)
ATC Code: J07BC
Marketing Authorisation Holder: Evans Vaccines Ltd.
Active Substance: hepatitis B, recombinant surface antigen
Status: Withdrawn
Authorisation Date: 2000-08-04
Therapeutic Area: Hepatitis B Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

This vaccine is indicated for active immunisation against hepatitis B virus infection in non-immune adults (>=18 years). The specific at risk categories to be immunised are to be determined on the basis of official recommendations.

The marketing authorisation for Hepacare has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide